FC
HAE icon

FORA Capital’s Haemonetics HAE Stock Holding History

FORA Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,468
Closed -$438K – 504
2025
Q4 		$438K Buy
+5,468
New +$367K 0.05% 317
2022
Q4 		– Sell
-4,772
Closed -$353K – 549
2022
Q3 		$353K Buy
+4,772
New +$343K 0.07% 302
2022
Q1 		– Sell
-4,725
Closed -$251K – 560
2021
Q4 		$251K Buy
+4,725
New +$288K 0.1% 258
2021
Q1 		– Sell
-2,279
Closed -$271K – 900
2020
Q4 		$271K Buy
+2,279
New +$245K 0.04% 439

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FORA Capital's HAE Position: Q1 2026 in Review

FORA Capital sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 5,468 shares — an estimated $438K sold.

FORA Capital first reported a position in HAE in Q4 2020 and held it in 4 quarters. The position peaked at $438K in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • FORA Capital reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • FORA Capital sold 5,468 Haemonetics shares in Q1 2026, an estimated $438K.
  • FORA Capital first reported a position in Haemonetics in Q4 2020 and held it in 4 quarters.
  • FORA Capital's Haemonetics position peaked at $438K in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.